Chargement en cours...
Intracranial hemorrhage in patients treated with bevacizumab: Report of two cases
Treatment with bevacizumab, an antiangiogenic agent, in patients with metastatic or unresectable colorectal cancer was approved less than 4 years ago in Japan. Bevacizumab improves the survival of patients with metastatic colorectal cancer; however, it may lead to complications such as bleeding, whi...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Co., Limited
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3218160/ https://ncbi.nlm.nih.gov/pubmed/22110272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v17.i39.4440 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|